Aliso Viejo, CA and State College, PA– December 3, 2009: Ambry
Genetics and SoftGenetics today announced the signing of an agreement to
provide extended bioinformatics genomics services using SoftGenetics’
NextGENe software for next-generation sequencing projects performed at
Ambry.
Anja Kammesheidt PhD, Ambry’s CSO said, “Our team at Ambry has been
providing genomics solutions on Illumina’s® Genome Analyzer platform
for 2 years now. In light of diversifying applications, increasing project
sizes, and new genomes to be explored, having a proven and innovative
partner for bioinformatics is key. While some of our clients are interested in
performing their own analyses, others are asking for extended support. We
have been impressed with SoftGenetics’ software tools, as well as their
approach to take care of the clients’ needs which is very much in line with
Ambry’s philosophy. We are looking forward to working together to provide
tailored services to our clients.”
Jonathan Liu PhD, SoftGenetics VP Research and Development echoed Dr.
Kammesheidt’s thoughts and added that “the SoftGenetics/Ambry
partnership provides a new strategic alliance that will not only provide a
single streamlined source for next-generation sequencing researchers but
will also provide SoftGenetics with a deepened vision of future researcher
requirements, allowing NextGENe to remain at the forefront of nextgeneration
sequencing software.”
“This highly unique alliance” , continued John Fosnacht, SoftGenetics VP
Sales and Marketing, “provides researchers wishing to utilize the power of
next-generation sequencing a distinctive value proposition by combining the
technical quality of Ambry Genetics sequencing with the unique analysis
capabilities of NextGENe without the heavy investment typically required in
next-generation sequencing instrumentation and bioinformatics. We all
believe this is a true win-win situation for everyone.”
“Next-generation sequencing services are more valuable to any scientific
researcher if you can offer a full menu for bioinformatics support” said Ardy
Arianpour, Director of Business Development, Genomic Services at Ambry
Genetics. “Ambry Genetics has now become the genomics community’s
one-stop service shop for next-generation sequencing services. We can
handle large projects and we can offer the most robust data analysis through
the exclusive alliance with SoftGenetics.”
Ambry Genetics has been providing next generation sequencing services to
pharmaceutical, biotech and academic clients for a wide range of
applications including targeted resequencing through custom or exome
sequence capture, transcriptome, ChIP and de novo sequencing. Ambry
Genetics is focused on delivering the highest quality results with the most
sensible workflows while maintaining cost effective contracts for the
genomics community.
About Ambry Genetics
Ambry Genetics is both a clinical, CAP-accredited and CLIA-certified
commercial laboratory as well as a genomics services laboratory
headquartered in Aliso Viejo, California. Since the company’s inception in
2000, it has become a leader in providing genetic services focused on
clinical diagnostics and genomic services. Ambry has built a solid reputation
for unparalleled service, and has been at the forefront of applying new
technologies to the clinical molecular diagnostics market and advancements
in disease research. To learn more about testing and services available
through Ambry, visit www.ambrygen.com.
About SoftGenetics
SoftGenetics, LLC, located in State College Pennsylvania specializes in the
development of genetic analysis tools for both research and diagnostic
applications. Hallmarks of SoftGenetics software tools are advanced
technologies, providing exceptional accuracy, and sensitivity in an easy-to
use Windows® user interface.
Its NextGENe software provides biologists with an easy-to-use software
analysis tool which improves Next Generation Sequencing accuracy in a
complete, freestanding Windows® based program. NextGENe virtually
eliminates bioinformatics requirements, utilizes low cost hardware, and is
compatible with all major NGS systems
To learn more or to request a 30-day trial of the software, please visit:
###
Genetics and SoftGenetics today announced the signing of an agreement to
provide extended bioinformatics genomics services using SoftGenetics’
NextGENe software for next-generation sequencing projects performed at
Ambry.
Anja Kammesheidt PhD, Ambry’s CSO said, “Our team at Ambry has been
providing genomics solutions on Illumina’s® Genome Analyzer platform
for 2 years now. In light of diversifying applications, increasing project
sizes, and new genomes to be explored, having a proven and innovative
partner for bioinformatics is key. While some of our clients are interested in
performing their own analyses, others are asking for extended support. We
have been impressed with SoftGenetics’ software tools, as well as their
approach to take care of the clients’ needs which is very much in line with
Ambry’s philosophy. We are looking forward to working together to provide
tailored services to our clients.”
Jonathan Liu PhD, SoftGenetics VP Research and Development echoed Dr.
Kammesheidt’s thoughts and added that “the SoftGenetics/Ambry
partnership provides a new strategic alliance that will not only provide a
single streamlined source for next-generation sequencing researchers but
will also provide SoftGenetics with a deepened vision of future researcher
requirements, allowing NextGENe to remain at the forefront of nextgeneration
sequencing software.”
“This highly unique alliance” , continued John Fosnacht, SoftGenetics VP
Sales and Marketing, “provides researchers wishing to utilize the power of
next-generation sequencing a distinctive value proposition by combining the
technical quality of Ambry Genetics sequencing with the unique analysis
capabilities of NextGENe without the heavy investment typically required in
next-generation sequencing instrumentation and bioinformatics. We all
believe this is a true win-win situation for everyone.”
“Next-generation sequencing services are more valuable to any scientific
researcher if you can offer a full menu for bioinformatics support” said Ardy
Arianpour, Director of Business Development, Genomic Services at Ambry
Genetics. “Ambry Genetics has now become the genomics community’s
one-stop service shop for next-generation sequencing services. We can
handle large projects and we can offer the most robust data analysis through
the exclusive alliance with SoftGenetics.”
Ambry Genetics has been providing next generation sequencing services to
pharmaceutical, biotech and academic clients for a wide range of
applications including targeted resequencing through custom or exome
sequence capture, transcriptome, ChIP and de novo sequencing. Ambry
Genetics is focused on delivering the highest quality results with the most
sensible workflows while maintaining cost effective contracts for the
genomics community.
About Ambry Genetics
Ambry Genetics is both a clinical, CAP-accredited and CLIA-certified
commercial laboratory as well as a genomics services laboratory
headquartered in Aliso Viejo, California. Since the company’s inception in
2000, it has become a leader in providing genetic services focused on
clinical diagnostics and genomic services. Ambry has built a solid reputation
for unparalleled service, and has been at the forefront of applying new
technologies to the clinical molecular diagnostics market and advancements
in disease research. To learn more about testing and services available
through Ambry, visit www.ambrygen.com.
About SoftGenetics
SoftGenetics, LLC, located in State College Pennsylvania specializes in the
development of genetic analysis tools for both research and diagnostic
applications. Hallmarks of SoftGenetics software tools are advanced
technologies, providing exceptional accuracy, and sensitivity in an easy-to
use Windows® user interface.
Its NextGENe software provides biologists with an easy-to-use software
analysis tool which improves Next Generation Sequencing accuracy in a
complete, freestanding Windows® based program. NextGENe virtually
eliminates bioinformatics requirements, utilizes low cost hardware, and is
compatible with all major NGS systems
To learn more or to request a 30-day trial of the software, please visit:
###